Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 11,608 | 9,872 | 8,715 | 14,111 | 6,315 |
| Cost of Goods | 1,229 | 1,032 | 1,205 | 2,396 | 962 |
| Gross Profit | 10,379 | 8,840 | 7,510 | 11,715 | 5,353 |
| Operating Expenses | 20,198 | 19,055 | 19,125 | 12,644 | 3,383 |
| Operating Income | -9,590 | -10,183 | -11,410 | -533 | 2,932 |
| Interest Expense | 263 | 285 | 301 | 249 | 5 |
| Other Income | 236 | 314 | 478 | 515 | 553 |
| Pre-tax Income | -9,617 | -10,154 | -11,233 | -267 | 3,480 |
| Income Tax | -2 | 1 | -3 | 4 | N/A |
| Net Income Continuous | -9,615 | -10,155 | -11,230 | -271 | 3,480 |
| Net Income | $-9,615 | $-10,155 | $-11,230 | $-271 | $3,480 |
| EPS Basic Total Ops | -0.76 | -0.80 | -0.88 | -0.04 | 0.28 |
| EPS Basic Continuous Ops | -0.75 | -0.79 | -0.91 | -0.02 | 0.29 |
| EPS Diluted Total Ops | -0.76 | -0.80 | -0.88 | -0.04 | 0.28 |
| EPS Diluted Continuous Ops | -0.75 | -0.79 | -0.91 | -0.02 | 0.29 |
| EBITDA(a) | $-9,284 | $-9,969 | $-11,152 | $-274 | $3,348 |